Literature DB >> 1997643

Pneumothorax in a patient with Wegener's granulomatosis during treatment with immunosuppressive agents.

M Ogawa1, R Azemoto, Y Makino, Y Mori, S Ueda, M Wakashin, M Ohto.   

Abstract

We present the case of a 16-year-old woman with Wegener's granulomatosis, who developed a pneumothorax while receiving treatment with cyclophosphamide and glucocorticoids. The lung was re-expanded by tube drainage, and the patient recovered completely while the immunosuppressive treatment was continued in combination with sulphamethoxazole-trimethoprim. A possible role for this antimicrobial drug in the treatment of Wegener's granulomatosis is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997643     DOI: 10.1111/j.1365-2796.1991.tb00329.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  4 in total

Review 1.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 2.  Unusual causes of pneumothorax.

Authors:  Daniel R Ouellette; Scott Parrish; Robert F Browning; J Francis Turner; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  Successful treatment of granulomatosis with polyangiitis with hydropneumothorax using corticosteroids and immunosuppressant.

Authors:  Xu-Hua Shi; Yong-Feng Zhang; Yue-Wu Lu
Journal:  Exp Ther Med       Date:  2017-05-08       Impact factor: 2.447

Review 4.  Risk factors and treatment of pneumothorax secondary to granulomatosis with polyangiitis: a clinical analysis of 25 cases.

Authors:  Xuhua Shi; Yongfeng Zhang; Yuewu Lu
Journal:  J Cardiothorac Surg       Date:  2018-01-15       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.